Gilead Sciences
GILD
#127
Rank
A$232.81 B
Marketcap
A$187.63
Share price
2.32%
Change (1 day)
27.39%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): A$15.32 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are A$29.08 Billion. In 2024 the company made an earning of A$1.04 Billion a decrease over its 2023 earnings that were of A$10.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$15.32 B1371.36%
2024 A$1.04 B-89.94%
2023 A$10.35 B17.97%
2022 A$8.77 B-29.77%
2021 A$12.49 B395.99%
2020 A$2.51 B-67.66%
2019 A$7.78 B-33.84%
2018 A$11.77 B-42.35%
2017 A$20.42 B-20.87%
2016 A$25.80 B-21.06%
2015 A$32.69 B45.8%
2014 A$22.42 B253.01%
2013 A$6.35 B16.51%
2012 A$5.45 B-1.07%
2011 A$5.51 B-6.71%
2010 A$5.90 B11.75%
2009 A$5.28 B29.5%
2008 A$4.08 B19.11%
2007 A$3.42 B-455.74%
2006 -A$0.97 Billion-154.93%
2005 A$1.75 B76.99%
2004 A$0.99 B-266.16%
2003 -A$0.6 Billion-638.24%
2002 A$0.11 B31.5%
2001 A$84.26 M-242.15%
2000 -A$59.28 Million-40.2%
1999 -A$99.13 Million31.85%
1998 -A$75.18 Million8.73%
1997 -A$69.14 Million27.22%
1996 -A$54.35 Million
1994 -A$51.78 Million26.57%
1993 -A$40.92 Million46.49%
1992 -A$27.93 Million362.5%
1991 -A$6.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Amgen
AMGN
A$12.44 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
A$6.73 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.50 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.50 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$2.87 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.89 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.90 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.97 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.85 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA